Health Economics and Patient-Centered Outcomes

Image from space of the horizon of Earth

The optimal path to market access is complex. You have to demonstrate clinical and economic value, meet the requirements that govern HTA submissions, and satisfy stakeholders at every turn. Lumanity illuminates a way forward. We’re the pharmaceutical health economics, patient-centered outcomes, and health technology assessment (HTA) partner that helps you to uncover the full potential of your products so that you can demonstrate their value to stakeholders around the world.

We Can Help You:

Our Impact

50+
HTA submissions supported per year worldwide
20+
Global markets in which we’ve supported HTA submissions and evidence development
1st
Supported the first HTA submissions to NICE in I-O and CAR-T, and nearly 25% of all NICE highly specialized technology (HST) submissions to date
40+
NICE appraisal meetings in which we represented our client partners
Pembrolizumab Receives NICE Approval for Five New Indications
Explore how MSD, a global biopharmaceutical leader, overcame complex challenges to secure UK approval for pembrolizumab, a revolutionary cancer immunotherapy. With the expertise and guidance from our HEOR experts, MSD achieved a historic full recommendation from NICE for treating multiple gastrointestinal cancers.
Case Study Sep 6, 2023
Let's Talk

We would love to hear your challenge and discuss how our team of health economics and patient-centered outcomes experts can help.

Our Team

Ron Akehurst, Executive Chairman at Lumanity
Ron Akehurst BSc, DSc, MFPH Executive Chair, HEOR
Read more about Ron Akehurst
Richard Birnie PhD Head of Advanced Analytics, HEOR
Read more about Richard Birnie
Ann-Marie Chapman
Ann-Marie Chapman VP Strategic Solutions, HEOR
Read more about Ann-Marie Chapman
Christopher J Evans MPH, MPhil, PhD President, Patient-Centered Outcomes
Read more about Christopher J Evans
Brandon Foster PhD Director, Statistics & Psychometrics, Patient-Centered Outcomes
Read more about Brandon Foster
Martha Gauthier Senior Director and Research Leader, Patient-Centered Outcomes
Read more about Martha Gauthier
Amber Gilbert MBA Global Practice Lead, Value, Access & Outcomes
Read more about Amber Gilbert
Dan Gladwell PhD Chief Scientific Officer, HEOR
Read more about Dan Gladwell
Nate Johnson MPH Director, Patient-Centered Outcomes
Read more about Nate Johnson
Jonathan Kowalski, Executive VP, Head of US HEOR at Lumanity
Jonathan Kowalski Executive Vice President, Head of US HEOR
Read more about Jonathan Kowalski
Sallie Latimer Head of HTA & Value Communications, HEOR
Read more about Sallie Latimer
Jeff Lee, VP, US Value Strategy and Services at Lumanity
Jeff Lee PharmD, FCCP Vice President, US Value Strategy and Services
Read more about Jeff Lee
Chrissy Lowry, Head of Health Economics Analysis at Lumanity
Chrissy Lowry Head of Health Economics and Statistics, HEOR
Read more about Chrissy Lowry
Julie Munakata MS Global President, HEOR
Read more about Julie Munakata
Headshot of William Renzo
William Renzo Executive Vice President, Market Access
Read more about William Renzo
David Robinson SVP Commercial Strategy & Operations
Read more about David Robinson
Julie Roiz SVP Regional Head, Europe, HEOR
Read more about Julie Roiz
Neil Roskell MS Chief Practice Officer, Modeling and Analytics
Read more about Neil Roskell
Headshot of Jamie Van Iderstine
Jamie Van Iderstine Executive Vice President, Market Access
Read more about Jamie Van Iderstine
Brooke Witherspoon Senior Director of Research and Operations, Patient-Centered Outcomes
Read more about Brooke Witherspoon